Characteristics of the gastric mucosa in patients with intestinal metaplasia

American Journal of Surgical Pathology

Volumn 39, Issue 5, 2015, Pages 700-704

  Genta, Robert M ^a,b   Sonnenberg, Amnon ^c  

^a MIRACA LIFE SCIENCES   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

gastric cancer; gastric intestinal metaplasia; gastritis; H. pylori; Helicobacter; preneoplastic lesions; reactive gastropathy

Indexed keywords

ADOLESCENT; ADULT; AGED; CHILD; FEMALE; HELICOBACTER INFECTIONS; HUMAN; INTESTINE; MALE; METAPLASIA; MICROBIOLOGY; MIDDLE AGED; PATHOLOGY; PRECANCEROUS CONDITIONS; PREVALENCE; STOMACH MUCOSA; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CHILD; FEMALE; GASTRIC MUCOSA; HELICOBACTER INFECTIONS; HUMANS; INTESTINES; MALE; METAPLASIA; MIDDLE AGED; PRECANCEROUS CONDITIONS; PREVALENCE; YOUNG ADULT;

EID: 84928584875     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0000000000000384     Document Type: Article

References (30)

1. Correa P, Piazuelo MB, Wilson KT. Pathology of gastric intestinal metaplasia: clinical implications. Am J Gastroenterol. 2010;105: 493-498.
2. Hirota WK, Zuckerman MJ, Adler DG, et al. ASGE guideline: the role of endoscopy in the surveillance of premalignant conditions of the upper GI tract. Gastrointest Endosc. 2006;63:570-580.
3. Correa P, Piazuelo MB. Natural history of Helicobacter pylori infection. Dig Liver Dis. 2008;40:490-496.
4. Dias-Neto M, Pintalhao M, Ferreira M, et al. Salt intake and risk of gastric intestinal metaplasia: systematic review and meta-analysis. Nutr Cancer. 2010;62:133-147.
5. Taborda AG, Prolla JC. Alimentary factors in the development of gastric intestinal metaplasia in functional dyspeptic patients. Arq Gastroenterol. 2012;49:208-213.
6. Peleteiro B, Bastos J, Barros H, et al. Systematic review of the prevalence of gastric intestinal metaplasia and its area-level association with smoking. Gac Sanit. 2008;22:236-247.
7. Leung WK, Ng EK, Chan WY, et al. Risk factors associated with the development of intestinal metaplasia in first-degree relatives of gastric cancer patients. Cancer Epidemiol Biomarkers Prev. 2005;14:2982-2986.
8. Matsuhisa T, Arakawa T, Watanabe T, et al. Relation between bile acid reflux into the stomach and the risk of atrophic gastritis and intestinal metaplasia: a multicenter study of 2283 cases. Dig Endosc. 2013;25:519-525.
9. Nordenstedt H, Graham DY, Kramer JR, et al. Helicobacter pylorinegative gastritis: prevalence and risk factors. Am J Gastroenterol. 2013;108:65-71.
10. Maguilnik I, Neumann WL, Sonnenberg A, et al. Reactive gastropathy is associated with inflammatory conditions throughout the gastrointestinal tract. Aliment Pharmacol Ther. 2012;36:736-743.
11. Genta RM, Lew GM, Graham DY. Changes in the gastric mucosa following eradication of Helicobacter pylori. Mod Pathol. 1993;6: 281-289.
12. Oberhuber G, Puspok A, Dejaco C, et al. Minimal chronic inactive gastritis: indicator of pre-existing Helicobacter pylori gastritis? Pathol Res Pract. 1996;192:1016-1021.
13. Franceschi F, Genta RM, Sepulveda AR. Gastric mucosa: longterm outcome after cure of Helicobacter pylori infection. J Gastroenterol. 2002;37(suppl 13):17-23, 17-23.
14. Dixon MF, Genta RM, Yardley JH, et al. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol. 1996;20:1161-1181.
15. Rugge M, Correa P, Dixon MF, et al. Gastric mucosal atrophy: interobserver consistency using new criteria for classification and grading. Aliment Pharmacol Ther. 2002;16:1249-1259.
16. Rugge M, Correa P, Di Mario F, et al. OLGA staging for gastritis: a tutorial. Dig Liver Dis. 2008;40:650-658.
17. Genta RM. Differential diagnosis of reactive gastropathy. Semin Diagn Pathol. 2005;22:273-283.
18. Lash JG, Genta RM. Adherence to the Sydney System guidelines increases the detection of Helicobacter gastritis and intestinal metaplasia in 400738 sets of gastric biopsies. Aliment Pharmacol Ther. 2013;38:424-431.
19. Sakai N, Tatsuta M, Hirasawa R, et al. Low prevalence of Helicobacter pylori infection in patients with hamartomatous fundic polyps. Dig Dis Sci. 1998;43:766-772.
20. Genta RM, Schuler CM, Robiou CI, et al. No association between gastric fundic gland polyps and gastrointestinal neoplasia in a study of over 100,000 patients. Clin Gastroenterol Hepatol. 2009;7: 849-854.
21. Tazaki S, Nozu F, Yosikawa N, et al. Sporadic fundic gland polyprelated adenomas occurred in non-atrophic gastric mucosa without Helicobacter pylori infection. Dig Endosc. 2011;23:182-186.
22. Cassaro M, Rugge M, Gutierrez O, et al. Topographic patterns of intestinal metaplasia and gastric cancer. Am J Gastroenterol. 2000; 95:1431-1438.
23. Leung WK, Sung JJ. Review article: intestinal metaplasia and gastric carcinogenesis. Aliment Pharmacol Ther. 2002;16:1209-1216.
24. Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013. Available at: http://globocan.iarc.fr. Accessed October 15, 2014.
25. Soerjomataram I, Lortet-Tieulent J, Parkin DM, et al. Global burden of cancer in 2008: a systematic analysis of disability-adjusted life-years in 12 world regions. Lancet. 2012;380:1840-1850.
26. Gonzalez CA, Sanz-Anquela JM, Gisbert JP, et al. Utility of subtyping intestinal metaplasia as marker of gastric cancer risk. A review of the evidence. Int J Cancer. 2013;133:1023-1032.
27. Andrew A, Wyatt JI, Dixon MF. Observer variation in the assessment of chronic gastritis according to the Sydney system. Histopathology. 1994;25:317-322.
28. Capelle LG, de Vries AC, Haringsma J, et al. The staging of gastritis with the OLGA system by using intestinal metaplasia as an accurate alternative for atrophic gastritis. Gastrointest Endosc. 2010;71: 1150-1158.
29. Chen XY, van der Hulst RW, Bruno MJ, et al. Interobserver variation in the histopathological scoring of Helicobacter pylori related gastritis. J Clin Pathol. 1999;52:612-615.
30. Leja M, Funka K, Janciauskas D, et al. Interobserver variation in assessment of gastric premalignant lesions: higher agreement for intestinal metaplasia than for atrophy. Eur J Gastroenterol Hepatol. 2013;25:694-699.